HomeAI · summaries
Storia in 11 fonti
UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners
"For our generics coverage, we view the group as relatively well-positioned given: AMRX (significant US infrastructure), TEVA..."
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
supplychaindive.com
Trump maps out 200% tariffs for generic pharmaceuticals
The president said Tuesday he would maintain duty-free treatment for qualifying goods the next two years before hiking the tariffs in ensuing years.
- ·
biopharmadive.com
Trump threatens tariffs on imported generic drugs
While the possibility of levies on branded pharmaceuticals have had a limited impact on drugmaker revenues, tariffs of up to 200% on copycat medicines could — depending on the…
